Manchester Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $370K | Buy |
4,273
+192
| +5% | +$18.4K | 0.05% | 197 |
|
|
2025
Q4 | $392K | Sell |
4,081
-705
| -15% | -$68.5K | 0.05% | 197 |
|
|
2025
Q3 | $456K | Sell |
4,786
-1,038
| -18% | -$95.4K | 0.06% | 205 |
|
|
2025
Q2 | $508K | Buy |
5,824
+180
| +3% | +$15.3K | 0.07% | 207 |
|
|
2025
Q1 | $507K | Buy |
5,644
+20
| +0.4% | +$1.79K | 0.06% | 194 |
|
|
2024
Q4 | $449K | Buy |
5,624
+228
| +4% | +$19.7K | 0.05% | 209 |
|
|
2024
Q3 | $486K | Sell |
5,396
-3
| -0.1% | -$252 | 0.06% | 202 |
|
|
2024
Q2 | $425K | Buy |
5,399
+41
| +0.8% | +$3.36K | 0.05% | 214 |
|
|
2024
Q1 | $467K | Buy |
5,358
+9
| +0.2% | +$768 | 0.06% | 196 |
|
|
2023
Q4 | $441K | Buy |
5,349
+449
| +9% | +$34.2K | 0.06% | 192 |
|
|
2023
Q3 | $384K | Sell |
4,900
-59
| -1% | -$4.94K | 0.06% | 190 |
|
|
2023
Q2 | $437K | Sell |
4,959
-2,531
| -34% | -$218K | 0.06% | 186 |
|
|
2023
Q1 | $604K | Buy |
7,490
+621
| +9% | +$50.6K | 0.08% | 159 |
|
|
2022
Q4 | $534K | Buy |
6,869
+2,216
| +48% | +$180K | 0.08% | 153 |
|
|
2022
Q3 | $376K | Sell |
4,653
-1,966
| -30% | -$177K | 0.07% | 151 |
|
|
2022
Q2 | $594K | Sell |
6,619
-184
| -3% | -$18.6K | 0.1% | 114 |
|
|
2022
Q1 | $755K | Buy |
6,803
+709
| +12% | +$74.9K | 0.11% | 112 |
|
|
2021
Q4 | $630K | Sell |
6,094
-923
| -13% | -$107K | 0.08% | 143 |
|
|
2021
Q3 | $880K | Buy |
7,017
+812
| +13% | +$105K | 0.12% | 110 |
|
|
2021
Q2 | $770K | Buy |
6,205
+106
| +2% | +$13.3K | 0.11% | 129 |
|
|
2021
Q1 | $720K | Buy |
6,099
+1,384
| +29% | +$162K | 0.11% | 136 |
|
|
2020
Q4 | $552K | Buy |
4,715
+985
| +26% | +$108K | 0.09% | 146 |
|
|
2020
Q3 | $388K | Sell |
3,730
-95
| -2% | -$9.54K | 0.06% | 162 |
|
|
2020
Q2 | $351K | Hold |
3,825
| – | – | 0.05% | 182 |
|
|
2020
Q1 | $345K | Buy |
3,825
+730
| +24% | +$77.7K | 0.06% | 169 |
|
|
2019
Q4 | $351K | Hold |
3,095
| – | – | 0.04% | 197 |
|
|
2019
Q3 | $336K | Hold |
3,095
| – | – | 0.04% | 189 |
|
|
2019
Q2 | $301K | Hold |
3,095
| – | – | 0.04% | 202 |
|
|
2019
Q1 | $282K | Sell |
3,095
-211
| -6% | -$18.9K | 0.04% | 200 |
|
|
2018
Q4 | $283K | Hold |
3,306
| – | – | 0.04% | 182 |
|
|
2018
Q3 | $325K | Hold |
3,306
| – | – | 0.05% | 178 |
|
|
2018
Q2 | $283K | Buy |
3,306
+3,099
| +1,497% | +$259K | 0.04% | 184 |
|
|
2018
Q1 | $17K | Sell |
207
-321
| -61% | -$26.5K | ﹤0.01% | 428 |
|
|
2017
Q4 | $43K | Buy |
528
+433
| +456% | +$34.7K | 0.01% | 361 |
|
|
2017
Q3 | $7K | Hold |
95
| – | – | ﹤0.01% | 441 |
|
|
2017
Q2 | $8K | Sell |
95
-2,625
| -97% | -$221K | ﹤0.01% | 437 |
|
|
2017
Q1 | $219K | Buy |
2,720
+2,625
| +2,763% | +$205K | 0.03% | 176 |
|
|
2016
Q4 | $7K | Hold |
95
| – | – | ﹤0.01% | 451 |
|
|
2016
Q3 | $8K | Hold |
95
| – | – | ﹤0.01% | 459 |
|
|
2016
Q2 | $8K | Hold |
95
| – | – | ﹤0.01% | 476 |
|
|
2016
Q1 | $7K | Sell |
95
-810
| -90% | -$61K | ﹤0.01% | 538 |
|
|
2015
Q4 | $70K | Buy |
905
+619
| +216% | +$46.6K | 0.01% | 382 |
|
|
2015
Q3 | $19K | Sell |
286
-1,000
| -78% | -$73.7K | ﹤0.01% | 550 |
|
|
2015
Q2 | $95K | Sell |
1,286
-1,561
| -55% | -$119K | 0.02% | 302 |
|
|
2015
Q1 | $222K | Sell |
2,847
-3,781
| -57% | -$287K | 0.04% | 193 |
|
|
2014
Q4 | $479K | Sell |
6,628
-658
| -9% | -$45.7K | 0.06% | 162 |
|
|
2014
Q3 | $451K | Buy |
7,286
+131
| +2% | +$8.33K | 0.06% | 156 |
|
|
2014
Q2 | $456K | Buy |
7,155
+1,621
| +29% | +$98.5K | 0.06% | 166 |
|
|
2014
Q1 | $341K | Buy |
5,534
+1,018
| +23% | +$59.3K | 0.05% | 206 |
|
|
2013
Q4 | $259K | Sell |
4,516
-237
| -5% | -$13.4K | 0.04% | 277 |
|
|
2013
Q3 | $253K | Sell |
4,753
-192
| -4% | -$10.3K | 0.04% | 281 |
|
|
2013
Q2 | $255K | Buy |
+4,945
| New | +$244K | 0.05% | 244 |
|
Other funds holding MDT
VCM
VPM
Manchester Capital Management's MDT Position: Q1 2026 in Review
Manchester Capital Management increased its Medtronic (MDT) stake by 4.7% in Q1 2026, buying an estimated $18.4K and bringing the position to 4,273 shares worth $370K. The position accounts for 0.05% of the portfolio, ranked #197.
Manchester Capital Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $880K in Q3 2021. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Manchester Capital Management held 4,273 shares of Medtronic worth $370K as of Q1 2026.
- Manchester Capital Management bought 192 Medtronic shares in Q1 2026, an estimated $18.4K.
- Medtronic made up 0.05% of Manchester Capital Management's portfolio in Q1 2026, its #197 holding.
- Manchester Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Manchester Capital Management's Medtronic position peaked at $880K in Q3 2021.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.